Search Results 521-530 of 15122 for alt

  1. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial) - Mayo Clinic

    Subjects whose alanine aminotransferase (ALT) and aspartate aminotransferase (AST) \> 2.5 times the upper limit of normal range. 7. Subjects who cannot ...

  2. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Aspartate transaminase (AST/SGOT) and alanine transaminase (ALT/SGPT) ≤ 2.5 x ULN;; Calculated creatinine clearance ≥30 mL/min using the Cockcroft-Gault ...

  3. Bret T. Petersen, M.D. - Doctors and Medical Staff - Mayo Clinic

    Alt Rep Joint Commission Ambulatory PTACAmerican Society for Gastrointestinal Endoscopy (ASGE). 2004 - 2007. ChairTechnology Committee, American Society for ...

  4. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) - Mayo Clinic

    Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST) ≥ 2.0 times the ULN. 13. Positive COVID-19 PCR test, or alternative nucleic acid ...

  5. Rheumatoid factor - Mayo Clinic

    Rheumatoid factor — This blood test can help diagnose autoimmune disorders such as rheumatoid arthritis, Sjogren syndrome and lupus.

  6. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Participation eligibility · Confirmed hepatic insufficiency or abnormal liver function (AST and/or ALT > 3 times the upper limit of normal). · Currently has a ...

  7. Paul M. Altrichter, M.D. - Doctors and Medical Staff - Mayo Clinic

    ResidentFamily Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

  8. Deucravacitinib (BMS-986165) in LPP and FFA - Mayo Clinic

    Have a history of disseminated/complicated herpes zoster (for example, ophthalmic zoster or CNS involvement). ALT or AST > 2 x upper limits of normal (ULN); ...

  9. Gingseng for Cancer Related Fatigue - Clinical Trials

    Alanine aminotransferase (ALT) or aspartate transaminase (AST) ≤ 3 x ULN;; Creatinine ≤ 1.5 x ULN. No clinical suspicion of hypothyroidism within 180 days ...

  10. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    * Alanine aminotransferase (ALT) OR aspartate transaminase (AST) ≤ 3.5 x upper limit of normal (ULN) (obtained ≤ 28 days prior to registration) * Total ...